The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

Blujepa, which treats UTIs in female patients aged 12 and up with common and uncomplicated infections, will hit the market in ...

GSK plc GSK announced that the FDA has approved its oral antibiotic gepotidacin for treating uncomplicated urinary tract ...

The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...

Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...

Mankind Pharma launches affordable empagliflozin in India for diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:30 Hrs [IST] Mankind Pharma has launched its affordable gen ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed ...

The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic ...

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at one-tenth of the original cost.

Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.

Forbes contributors publish independent expert analyses and insights. Brian Mazique has covered combat sports and video games since 2011.

In terms of motor output, the MG Windsor EV makes 14 PS and 10 Nm more ... Tata Punch EV boasts a dual 10.25-inch screen system (touchscreen and digital driver display), wireless phone charger ...